IP protection

Kephera has applied for patent protection for our MiCRIA™ Open POC platform, including our microfluidic assay device and rapid binding assay method. We also have a patent-pending Lyme disease test using a novel combination of antigens in an ELISA-based method.

To learn more and to explore an investment relationship with Kephera Diagnostics, contact info@kephera.com